|
Index of reports
> Cases resulting in a serious event (23)
> Cases with Confusional State (6)
Below is the selection of adverse event reports related to MS Contin (Morphine) that includes cases resulting in a serious event where reactions include confusional state.
Adverse event in male receiving MS Contin (Morphine)
Reported by a individual with unspecified qualification on 2007-10-12
Patient: male
Adverse reactions / side effects: Confusional State, Paranoia, Hallucination, Delusion, Aggression
Suspect drug(s):
Desyrel
Dosage: 75 mg, daily
Indication: Drug USE FOR Unknown Indication
Morphine Sulfate
Dosage: 5 mg, prn
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
MS Contin
Dosage: unk, unk
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Adverse event in 42 year old female receiving MS Contin (Morphine)
Reported by a physician from United States on 2007-06-27
Patient: 42 year old female
Adverse reactions / side effects: Confusional State, Dyspnoea, Neuropathy Peripheral, Abnormal Behaviour, Drug Interaction, Mood Swings, Disease Progression
Suspect drug(s):
MS Contin
Dosage: 15 mg qd po
Administration route: Oral
Indication: Complex Regional Pain Syndrome
Start date: 2006-10-01
Namenda
Dosage: 10 mg bid po
Administration route: Oral
Indication: Neuropathy Peripheral
Start date: 2006-01-01
End date: 2006-12-13
Namenda
Dosage: 5 mg bid po
Administration route: Oral
Indication: Neuropathy Peripheral
Start date: 2006-12-14
End date: 2006-12-20
Namenda
Dosage: 5 mg qd po
Administration route: Oral
Indication: Neuropathy Peripheral
Start date: 2006-11-01
End date: 2006-01-01
Namenda
Dosage: 5 mg bid po
Administration route: Oral
Indication: Neuropathy Peripheral
Start date: 2006-01-01
End date: 2006-01-01
Namenda
Dosage: 15 mg qd po
Administration route: Oral
Indication: Neuropathy Peripheral
Start date: 2006-01-01
End date: 2006-01-01
Other drugs received by patient: Warfarin Sodium; Crestor; Darvocet; Spiriva; Levoxyl; Oxygen
Adverse event in 42 year old female receiving MS Contin (Morphine)
Reported by a physician from United States on 2007-05-09
Patient: 42 year old female
Adverse reactions / side effects: Back Pain, Confusional State, Dyspnoea, Abnormal Behaviour, Condition Aggravated, Drug Interaction, Cognitive Disorder, Amnesia, Complex Regional Pain Syndrome, Neuropathy Peripheral, Mood Swings
Suspect drug(s):
MS Contin
Dosage: 15 mg qd po
Administration route: Oral
Indication: Complex Regional Pain Syndrome
Start date: 2006-10-01
Namenda
Dosage: 10 mg bid po
Administration route: Oral
Indication: Neuropathy Peripheral
Start date: 2006-01-01
End date: 2006-12-13
Namenda
Dosage: 5 mg bid po
Administration route: Oral
Indication: Neuropathy Peripheral
Start date: 2006-12-14
End date: 2006-12-20
Namenda
Dosage: 5 mg qd po
Administration route: Oral
Indication: Neuropathy Peripheral
Start date: 2006-11-01
End date: 2006-01-01
Namenda
Dosage: 5 mg bid po
Administration route: Oral
Indication: Neuropathy Peripheral
Start date: 2006-01-01
End date: 2006-01-01
Namenda
Dosage: 15 mg qd po
Administration route: Oral
Indication: Neuropathy Peripheral
Start date: 2006-01-01
End date: 2006-01-01
Other drugs received by patient: Warfarin Sodium; Crestor; Darvocet; Spiriva; Levoxyl; Oxygen
Adverse event in 56 year old male receiving MS Contin (Morphine)
Reported by a individual with unspecified qualification on 2007-04-16
Patient: 56 year old male
Adverse reactions / side effects: Confusional State, Nausea, Therapeutic Agent Toxicity, Somnolence, Anticonvulsant Drug Level Increased, Dizziness, Gait Disturbance, Neutropenia, Thrombocytopenia
Adverse event resulted in: disablity
Suspect drug(s):
Dilantin
Dosage: 300 mg, unk
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
MS Contin
Dosage: 20 mg, unk
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Sutent
Dosage: 50 mg, unk
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Adverse event in 56 year old male receiving MS Contin (Morphine)
Reported by a individual with unspecified qualification on 2007-04-12
Patient: 56 year old male
Adverse reactions / side effects: Confusional State, Nausea, Therapeutic Agent Toxicity, Somnolence, Anticonvulsant Drug Level Increased, Dizziness, Gait Disturbance, Neutropenia, Thrombocytopenia
Adverse event resulted in: disablity
Suspect drug(s):
Dilantin
Dosage: 300 mg, unk
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
MS Contin
Dosage: 20 mg, unk
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Sutent
Dosage: 50 mg, unk
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Adverse event in 42 year old female receiving MS Contin (Morphine)
Reported by a physician from United States on 2007-03-13
Patient: 42 year old female
Adverse reactions / side effects: Back Pain, Confusional State, Dyspnoea, Abnormal Behaviour, Drug Interaction, Amnesia, Disease Progression, Hyperaesthesia, Neuropathy Peripheral, Mood Swings
Suspect drug(s):
MS Contin
Dosage: 15 mg qd po
Administration route: Oral
Indication: Complex Regional Pain Syndrome
Start date: 2006-10-01
Namenda
Dosage: 10 mg bid po
Administration route: Oral
Indication: Neuropathy Peripheral
Start date: 2006-01-01
End date: 2006-12-13
Namenda
Dosage: 5 mg bid po
Administration route: Oral
Indication: Neuropathy Peripheral
Start date: 2006-12-14
End date: 2006-12-20
Namenda
Dosage: 5 mg qd po
Administration route: Oral
Indication: Neuropathy Peripheral
Start date: 2006-11-01
End date: 2006-01-01
Namenda
Dosage: 5 mg bid po
Administration route: Oral
Indication: Neuropathy Peripheral
Start date: 2006-01-01
End date: 2006-01-01
Namenda
Dosage: 15 mg qd po
Administration route: Oral
Indication: Neuropathy Peripheral
Start date: 2006-01-01
End date: 2006-01-01
Other drugs received by patient: Warfarin Sodium; Crestor; Darvocet (Propoxyphene / Acetaminophen); Spiriva; Levoxyl; Oxygen
|
